AbbVie will pay $10 billion for Immunogen, acquiring an approved treatment for o...
AbbVie will pay $10 billion for the biotech firm Immunogen, the company said, ac...
Diagnostic tests for rare conditions present a mathematical conundrum.
The Bacterial Conjunctivitis drugs in development market research report provide...
The Gliosarcoma drugs in development market research report provides comprehensi...
The Uveitis drugs in development market research report provides comprehensive i...
The Cataract drugs in development market research report provides comprehensive ...
The Respiratory Syncytial Virus (RSV) Infections drugs in development market res...
The Liver Transplant Rejection drugs in development market research report provi...
The Peptic Ulcers drugs in development market research report provides comprehen...
The Herpes Labialis (Oral Herpes) drugs in development market research report pr...
The Heart Transplant Rejection drugs in development market research report provi...
Biden's plan to stem drug shortages involves using a Cold War-era law to bring d...
An FDA investigation into links between CAR-T immunotherapy and new cancers come...
Data from half a million people’s whole genome sequences are now available to re...
Cigna and Humana are in discussions to merge, a potential move that would create...
